Potenza Therapeutics Competitors and Similar CompaniesClear all

Potenza Therapeutics's competitors and similar companies include PolarityTE, Ultima Genomics, Quantum-Si and Hemarina.

	Potenza Therapeutics Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity	PolarityTE PolarityTE, Inc. is a regenerative medicine company positioned to be the first to successfully regenerate human skin.	Ultima Genomics Ultima Genomics (UG) is a company that develops genome-scale sequencing technology.	Quantum-Si Quantum-Si Incorporated (QSI) is a biotechnology company that provides protein sequencing technology solutions.	Hemarina Hemarina is a biotechnology company centered on the research and development of marine oxygen carriers for therapeutic and industrial applications.
Founding Date	Founding Date 2014	Founding Date 1986	Founding Date 2016	Founding Date 2013	Founding Date N/A
Type	Type Subsidiary	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech healthtech	Tags Healthcare biotech healthtech	Tags Healthcare biotech genetics healthtech	Tags Healthcare biotech healthtech	Tags Healthcare biotech healthtech
Locations	Locations Cambridge, US HQ	Locations Salt Lake City, US HQ Salt Lake City, US	Locations Fremont, US HQ	Locations Branford, US HQ	Locations Morlaix, FR HQ
Employees	Employees 4	Employees 15627% increase	Employees 3142% increase	Employees 16518% decrease	Employees 186
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.8 m	Valuation ($) N/A	Valuation ($) 109.7 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $814k (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $2.4m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $616k (FY, 2022)	Cost of goods N/A	Cost of goods $1.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $198k (FY, 2022)	Gross profit N/A	Gross profit $1.2m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($7.8m) (FY, 2022)	Net income N/A	Net income ($101.3m) (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 600m (about 4 years ago)	Latest funding round N/A	Latest funding round $ 3.7m (about 16 years ago)
Total funding raised	Total funding raised $ 30m	Total funding raised N/A	Total funding raised $ 600m	Total funding raised N/A	Total funding raised $ 4.8m